Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2013 (2013), Article ID 434618, 5 pages
Clinical Study

The Influence of Long Term Hydrochlorothiazide Administration on the Relationship between Renin-Angiotensin-Aldosterone System Activity and Plasma Glucose in Patients with Hypertension

1Department of Emergency Medicine, The Sichuan Provincial People’s Hospital, Chengdu 610072, China
2Department of Ophthalmology, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA 92093, USA

Received 6 August 2013; Accepted 4 October 2013

Academic Editor: Yan Chen

Copyright © 2013 Xu Xiao et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Objective. To observe the relationship between changes in renin-angiotensin-aldosterone system (RAAS) activity and blood plasma glucose after administration of hydrochlorothiazide (HCTZ) for one year in patients with hypertension. Methods. 108 hypertensive patients were given 12.5 mg HCTZ per day for one year. RAAS activity, plasma glucose levels, and other biochemical parameters, as well as plasma oxidized low density lipoprotein (oxLDL) levels, were measured and analyzed at baseline, six weeks, and one year after treatment. Results. After one year of treatment, the reduction in plasma glucose observed between the elevated plasma renin activity (PRA) group (  mmol/L) and the nonelevated PRA group (  mmol/L) was statistically significant ( ). The decrease of plasma glucose in the elevated Ang II group (  mmol/L) compared to the nonelevated Ang II group (  mmol/L) was statistically significant ( ). The proportion of patients with elevated plasma glucose in the elevated Ang II group (40.5%) was significantly higher than those in the nonelevated Ang II group (16.3%) ( ). The relative oxLDL level was not affected by the treatment. Conclusions. Changes in RAAS activity were correlated with changes in plasma glucose levels after one year of HCTZ therapy.